Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
NASDAQ:EARS
Delisted

Auris Medical Holding AG Stock Price (Quote)

$0.750
-0.0010 (-0.133%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $0.680 $1.00 Friday, 27th May 2022 EARS stock ended at $0.750. This is 0.133% less than the trading day before Thursday, 26th May 2022. During the day the stock fluctuated 10.68% from a day low at $0.740 to a day high of $0.82.
90 days $0.635 $2.14
52 weeks $0.635 $4.58

Historical Auris Medical Holding AG prices

Date Open High Low Close Volume
Aug 25, 2016 $2.04 $2.04 $2.00 $2.03 593 700
Aug 24, 2016 $2.04 $2.05 $2.00 $2.04 963 900
Aug 23, 2016 $2.03 $2.05 $2.01 $2.03 629 800
Aug 22, 2016 $2.10 $2.10 $2.00 $2.02 1 687 200
Aug 19, 2016 $2.20 $2.25 $2.06 $2.12 2 169 900
Aug 18, 2016 $2.28 $2.32 $1.95 $2.15 12 958 300
Aug 17, 2016 $4.45 $5.45 $4.10 $5.35 3 169 600
Aug 16, 2016 $3.80 $3.89 $3.79 $3.84 215 700
Aug 15, 2016 $4.32 $4.33 $3.60 $3.79 335 600
Aug 12, 2016 $4.38 $4.54 $4.23 $4.28 136 500
Aug 11, 2016 $4.39 $4.48 $4.31 $4.37 77 300
Aug 10, 2016 $4.37 $4.37 $4.12 $4.35 92 300
Aug 09, 2016 $4.48 $4.55 $4.28 $4.32 177 300
Aug 08, 2016 $4.74 $4.85 $4.45 $4.49 142 200
Aug 05, 2016 $4.85 $4.87 $4.55 $4.62 344 400
Aug 04, 2016 $3.99 $4.89 $3.93 $4.73 788 600
Aug 03, 2016 $4.07 $4.07 $3.91 $3.95 43 600
Aug 02, 2016 $4.14 $4.21 $3.81 $4.03 128 800
Aug 01, 2016 $4.05 $4.26 $4.05 $4.14 109 400
Jul 29, 2016 $4.02 $4.06 $3.92 $4.01 46 900
Jul 28, 2016 $4.09 $4.32 $3.95 $4.01 79 100
Jul 27, 2016 $3.90 $4.16 $3.90 $4.07 104 600
Jul 26, 2016 $3.81 $4.00 $3.69 $3.90 60 400
Jul 25, 2016 $3.75 $3.84 $3.69 $3.76 42 300
Jul 22, 2016 $3.80 $3.90 $3.70 $3.70 49 400
Click to get the best stock tips daily for free!

About Auris Medical Holding AG

Auris Medical Holding AG Auris Medical Holding AG, a clinical-stage biopharmaceutical company, focuses on the development of novel products for the treatment of inner ear disorders. Its lead product candidate includes AM-101, which is in Phase III clinical development for treating acute inner ear tinnitus. The company is also developing AM-111 for the treatment of acute sensorineural hearing loss; and other pre-clinical stage products comprising AM-102 and AM-123. It has... EARS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT